IPCA Laboratories Limited

New PositionQuarterly

IPCALABPharmaceuticalsMarket Cap₹51K Cr

Stake

1.05%

HSBC Mutual Fund

Mutual Fund

The move

HSBC Mutual Fund entered IPCA Laboratories Limited with 26,76,396 shares, acquiring a 1.05% stake worth ₹48.71 Cr at ₹1823.30 apiece.

About IPCA Laboratories Limited

Visit stock

A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.

About HSBC Mutual Fund

Visit investor

Indian arm of HSBC Asset Management, the investment arm of HSBC Group with over USD 600 billion in global AUM. Manages over Rs 1 lakh crore in India across equity, debt and hybrid schemes. Previously known for integration of L&T Mutual Fund schemes after acquiring it from L&T Finance in 2022, which significantly expanded the franchise.

Get the next move the moment it happens.

Follow HSBC Mutual Fund and IPCA Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

IPCA Laboratories Limited shareholders HSBC Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in IPCA Laboratories Limited

Axis Mutual FundIncreased

Axis Mutual Fund increased its stake in IPCA Laboratories from 1.83% to 1.94%, buying 2,78,227 shares at ₹1920.40 apiece, for a total value of ₹53.43 Cr.

19 Jul 2026

Edelweiss Mutual FundIncreased

Edelweiss Mutual Fund increased its stake in IPCA Laboratories Limited from 1.03% to 1.19%, raising its shareholding from 2,602,635 to 3,019,905 shares. This represents an increase of 417,270 shares.